These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

446 related items for PubMed ID: 30790612

  • 1. SEDDS for intestinal absorption of insulin: Application of Caco-2 and Caco-2/HT29 co-culture monolayers and intra-jejunal instillation in rats.
    Liu J, Werner U, Funke M, Besenius M, Saaby L, Fanø M, Mu H, Müllertz A.
    Int J Pharm; 2019 Apr 05; 560():377-384. PubMed ID: 30790612
    [Abstract] [Full Text] [Related]

  • 2. Monoacyl phosphatidylcholine inhibits the formation of lipid multilamellar structures during in vitro lipolysis of self-emulsifying drug delivery systems.
    Tran T, Siqueira SDVS, Amenitsch H, Rades T, Müllertz A.
    Eur J Pharm Sci; 2017 Oct 15; 108():62-70. PubMed ID: 27890596
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of self-emulsifying drug delivery systems for oral insulin delivery using an in vitro model simulating the intestinal proteolysis.
    Liu J, Hirschberg C, Fanø M, Mu H, Müllertz A.
    Eur J Pharm Sci; 2020 Apr 30; 147():105272. PubMed ID: 32084584
    [Abstract] [Full Text] [Related]

  • 4. In vitro and in vivo performance of monoacyl phospholipid-based self-emulsifying drug delivery systems.
    Tran T, Siqueira SDVS, Amenitsch H, Müllertz A, Rades T.
    J Control Release; 2017 Jun 10; 255():45-53. PubMed ID: 28365295
    [Abstract] [Full Text] [Related]

  • 5. SEDDS facilitate cinnamaldehyde crossing the mucus barrier: The perspective of mucus and Caco-2/HT29 co-culture models.
    Cai Y, Liu L, Xia M, Tian C, Wu W, Dong B, Chu X.
    Int J Pharm; 2022 Feb 25; 614():121461. PubMed ID: 35026310
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Evaluation of drug permeation under fed state conditions using mucus-covered Caco-2 cell epithelium.
    Birch D, Diedrichsen RG, Christophersen PC, Mu H, Nielsen HM.
    Eur J Pharm Sci; 2018 Jun 15; 118():144-153. PubMed ID: 29524592
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Enhancing Oral Bioavailability of Domperidone Maleate: Formulation, In vitro Permeability Evaluation In-caco-2 Cell Monolayers and In situ Rat Intestinal Permeability Studies.
    Okur NÜ, Çağlar EŞ, Kaynak MS, Diril M, Özcan S, Karasulu HY.
    Curr Drug Deliv; 2024 Jun 15; 21(7):1010-1023. PubMed ID: 36786136
    [Abstract] [Full Text] [Related]

  • 10. Formulation and characterization of self-nanoemulsifying drug delivery systems containing monoacyl phosphatidylcholine.
    Tran T, Xi X, Rades T, Müllertz A.
    Int J Pharm; 2016 Apr 11; 502(1-2):151-60. PubMed ID: 26915809
    [Abstract] [Full Text] [Related]

  • 11. A tunable Caco-2/HT29-MTX co-culture model mimicking variable permeabilities of the human intestine obtained by an original seeding procedure.
    Béduneau A, Tempesta C, Fimbel S, Pellequer Y, Jannin V, Demarne F, Lamprecht A.
    Eur J Pharm Biopharm; 2014 Jul 11; 87(2):290-8. PubMed ID: 24704198
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Impact of Lipid-Based Drug Delivery Systems on the Transport and Uptake of Insulin Across Caco-2 Cell Monolayers.
    Li P, Nielsen HM, Müllertz A.
    J Pharm Sci; 2016 Sep 11; 105(9):2743-2751. PubMed ID: 26921121
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Absorption enhancing effect of labrasol on the intestinal absorption of insulin in rats.
    Eaimtrakarn S, Rama Prasad YV, Ohno T, Konishi T, Yoshikawa Y, Shibata N, Takada K.
    J Drug Target; 2002 May 11; 10(3):255-60. PubMed ID: 12075827
    [Abstract] [Full Text] [Related]

  • 16. Microcontainers for oral insulin delivery - In vitro studies of permeation enhancement.
    Jørgensen JR, Jepsen ML, Nielsen LH, Dufva M, Nielsen HM, Rades T, Boisen A, Müllertz A.
    Eur J Pharm Biopharm; 2019 Oct 11; 143():98-105. PubMed ID: 31425857
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.